Treatment of drug-resistant tuberculosis. An official ATS/CDC/ERS/IDSA clinical practice guideline
Background: The American Thoracic Society, US Centers for Disease Control and
Prevention, European Respiratory Society, and Infectious Diseases Society of America
jointly sponsored this new practice guideline on the treatment of drug-resistant tuberculosis
(DR-TB). The document includes recommendations on the treatment of multidrug-resistant
TB (MDR-TB) as well as isoniazid-resistant but rifampin-susceptible TB. Methods: Published
systematic reviews, meta-analyses, and a new individual patient data meta-analysis from …
Prevention, European Respiratory Society, and Infectious Diseases Society of America
jointly sponsored this new practice guideline on the treatment of drug-resistant tuberculosis
(DR-TB). The document includes recommendations on the treatment of multidrug-resistant
TB (MDR-TB) as well as isoniazid-resistant but rifampin-susceptible TB. Methods: Published
systematic reviews, meta-analyses, and a new individual patient data meta-analysis from …
Treatment of drug-resistant tuberculosis an official ATS/CDC/ERS/IDSA clinical practice guideline
American Thoracic Society… - … of respiratory and …, 2019 - researchwithrutgers.com
Background: The American Thoracic Society, US Centers for Disease Control and
Prevention, European Respiratory Society, and Infectious Diseases Society of America
jointly sponsored this new practice guideline on the treatment of drug-resistant tuberculosis
(DR-TB). The document includes recommendations on the treatment of multidrug-resistant
TB (MDR-TB) as well as isoniazid-resistant but rifampin-susceptible TB. Methods: Published
systematic reviews, meta-analyses, and a new individual patient data meta-analysis from …
Prevention, European Respiratory Society, and Infectious Diseases Society of America
jointly sponsored this new practice guideline on the treatment of drug-resistant tuberculosis
(DR-TB). The document includes recommendations on the treatment of multidrug-resistant
TB (MDR-TB) as well as isoniazid-resistant but rifampin-susceptible TB. Methods: Published
systematic reviews, meta-analyses, and a new individual patient data meta-analysis from …
以上显示的是最相近的搜索结果。 查看全部搜索结果